BioMarin Pharmaceutical
BMRN
C$80.18
Share price
0.15%
Change (1 day)
-31.14%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Total assets
Total assets on the balance sheet as of March 2025 : C$9.84 Billion
According to BioMarin Pharmaceutical's latest financial reports the company's total assets are C$9.84 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
BioMarin Pharmaceutical - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | C$10.02 B | 10.52% |
| 2023-12-31 | C$9.07 B | 4.9% |
| 2022-12-31 | C$8.65 B | 13.04% |
| 2021-12-31 | C$7.65 B | 2.63% |
| 2020-12-31 | C$7.45 B | 21.73% |
| 2019-12-31 | C$6.12 B | 1.57% |
| 2018-12-31 | C$6.03 B | 3.53% |
| 2017-12-31 | C$5.82 B | 7.73% |
| 2016-12-31 | C$5.40 B | 4.52% |
| 2015-12-31 | C$5.17 B | 80.09% |
| 2014-12-31 | C$2.87 B | 20.25% |
| 2013-12-31 | C$2.38 B | 53.17% |
| 2012-12-31 | C$1.55 B | 17.42% |
| 2011-12-31 | C$1.32 B | 5.23% |
| 2010-12-31 | C$1.26 B | 30.78% |
| 2009-12-31 | C$0.96 B | -12.46% |
| 2008-12-31 | C$1.10 B | 35.55% |
| 2007-12-31 | C$0.81 B | 50.73% |
| 2006-12-31 | C$0.53 B | 137.3% |
| 2005-12-31 | C$0.22 B | -18.74% |
| 2004-12-31 | C$0.27 B | -15.85% |
| 2003-12-31 | C$0.33 B | 90.33% |
| 2002-12-31 | C$0.17 B | -36.17% |
| 2001-12-31 | C$0.27 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | C$1.80 B | -81.64% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | C$0.11 B | -98.79% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | C$0.44 B | -95.47% | 🇺🇸 USA |
 Sanofi SNY | C$196.46 B | 1,896.53% | 🇫🇷 France |
 Amicus Therapeutics
FOLD | C$1.08 B | -88.95% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | C$1.25 B | -87.28% | 🇺🇸 USA |